Evidence map›Paper›PMID 34375156›Full record

ArticleAmyotrophic lateral sclerosis & frontotemporal degeneration2022

Predicting dysphagia onset in patients with ALS: the ALS dysphagia risk score.

Bridget J Perry, J Nelson, J B Wong, D M Kent, Pooled Resource Open-Access ALS Clinical Trials Consortium

Open access · greenAbstract read
In one paragraph

Article in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Practical recommendations for swallowing and speaking during NIV in people with neuromuscular disorders.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2024
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Bridget J PerryClinical and Translational Sciences Institute, Tufts Medical Center, Boston, MA, USA.
J NelsonClinical and Translational Sciences Institute, Tufts Medical Center, Boston, MA, USA.
J B WongDivision of Clinical Decision Making, Department of Medicine, Tufts Medical Center, Boston, MA, USA.
D M KentClinical and Translational Sciences Institute, Tufts Medical Center, Boston, MA, USA.
Pooled Resource Open-Access ALS Clinical Trials Consortium
Tufts Medical Center · USMGH Institute of Health Professions · US

Funding

Tufts Clinical and Translational Science Institute (Pilot Supplement)UL1TR002544 · NCATS · TUFTS UNIVERSITY BOSTON · PI SELKER, HARRY P. · 2018 to 2022
$50.2M
CTSA Graduate ProgramTL1TR002546 · NCATS · TUFTS UNIVERSITY BOSTON · PI KENT, DAVID M · 2018 to 2022
$4.2M
NCATS NIH HHS TL1 TR002546NCATS NIH HHS UL1 TR002544
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Amyotrophic Lateral SclerosisDeglutition DisordersDisease ProgressionHumansModels, StatisticalPrognosisRetrospective StudiesRisk FactorsALSamyotrophic lateral sclerosisDysphagiasurvivalswallowing

Identifiers

PMID34375156
PMCPMC9782713
OpenAlexW3190557804

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.